CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2004-04-24 | CAMPBELL MARY L Director | Purchase | +285 | $0.88 | $251 | 1,092 |
| 2004-04-21 | FINGERLE LINDA M Director | Purchase | +441 | $1.13 | $498 | 1,441 |
| 2004-04-21 | CAMPBELL MARY L Director | Purchase | +220 | $1.13 | $249 | 807 |
| 2004-04-21 | FINGERLE LINDA M Director | Purchase | +385 | $1.13 | $435 | 1,385 |
| 2004-04-21 | CAMPBELL MARY L Director | Purchase | +192 | $1.13 | $217 | 779 |
| 2004-03-17 | CAMPBELL MARY L Director | Purchase | +187 | $1.33 | $249 | 587 |
| 2004-03-03 | FINGERLE LINDA M Director | Purchase | +1,000 | $1.54 | $2K | 1,000 |
| 2003-11-12 | CAMPBELL MARY L Director | Grant or award · Stock Option (Right to buy) | +10,000 | $1.32 | $13K | 10,000 |
| 2003-11-12 | TAYLOR JOSEPH A Director | Grant or award · Stock Option (Right to buy) | +10,000 | $1.32 | $13K | 10,000 |
| 2003-11-12 | STAUBITZ ARTHUR Director | Grant or award · Stock Option (Right to buy) | +10,000 | $1.32 | $13K | 10,000 |
| 2003-11-12 | STAUBITZ ARTHUR Director | Grant or award · Stock Option (Right to buy) | +5,000 | $1.32 | $7K | 5,000 |
| 2003-11-12 | WYANT SUSAN Director | Grant or award · Stock Option (Right to buy) | +10,000 | $1.32 | $13K | 10,000 |
| 2003-11-12 | BARD ROBERT VP QS and RA | Grant or award · Stock Option (Right to buy) | +25,000 | $1.32 | $33K | 25,000 |
| 2003-09-19 | ARMSTRONG R DOUGLAS PHD President & CEO | Grant or award · Stock Option (Right to Buy) | +200,000 | $1.64 | $328K | 200,000 |
| 2003-09-19 | BARD ROBERT VP Regulatory Affiars | Grant or award · Stock Option (Right to Buy) | +20,000 | $1.64 | $33K | 20,000 |
| 2003-09-19 | HAMPSON BRIAN Vice-Presidnet Product Develop | Grant or award · Stock Option (Right to Buy) | +69,000 | $1.64 | $113K | 69,000 |
| 2003-09-19 | WRIGHT ALAN M Vice-President Finance, CFO | Grant or award · Stock Option (Right to Buy) | +84,000 | $1.64 | $138K | 84,000 |
| 2003-04-25 | ARMSTRONG R DOUGLAS PHD President & CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | $0.40 | $120K | 300,000 |
Page 81 of 81 · 1,618 trades